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The number of ultra high ﬁeld MR systems, mostly 7 T systems,
installed in environments with clinical connections is steadily
increasing. Based on a higher signal to noise ratio, expectations are
that 7 T systems will improve clinical diagnostics. This also includes
functional diagnostics, which relies on increased sensitivity to the
BOLD (Blood Oxygenation Level Dependent) effect (Olman et al.,
2010; van der Zwaag et al., 2009).
Despite this background, results from 7 T patient studies are yet
scarce. A small number of initial patient investigations and feasibility
studies have compared 7 T data with data from 3 T, 1.5 T or data from
literature. They have indicated 7 T beneﬁts for morphological di-
agnostics, including improved detection of multiple sclerosis plaques
(Kollia et al., 2009; Metcalf et al., 2010), improved detection of
pathologies in Alzheimer's disease (Nakada et al., 2008) and improved
classiﬁcation of brain lesions (Moenninghoff et al., 2010; Tallantyre
et al., 2009). Beneﬁts have also been described for angiographicdetection of small vessel changes in hypertensive patients (Kang
et al., 2009) and spectroscopic investigations of brain tumors
(Avdievich et al., 2009). However, to date, no functional patient
investigations have been performed at 7 T to examine possible
beneﬁts for functional diagnostics (e.g. presurgical localization of
essential cortical areas using fMRI).
Clinical fMRI offers considerable potential to reduce invasive
diagnostic procedures and is already routinely applied in specialized
diagnostic centers (for a recent review see Prayer et al., 2010). A
recent fMRI study of healthy subjects comparing functional results at
1.5, 3 and 7 T showed several 7 T beneﬁts based on an increased
ΔR2*/R2* ratio (van der Zwaag et al., 2009). However, there are also
several drawbacks of high ﬁeld systems which may counteract
improved BOLD sensitivity, in particular in patients with pathological
brains. The most important issues are increased susceptibility
artifacts, reduced homogeneity of the transmitted radiofrequency
ﬁeld and potentially larger motion artifacts. Due to brain pathology
and the patients’ limited abilities to cooperate, these issues may result
in increased image distortions, local artifacts and signal dropouts
compared to healthy subjects. As a consequence, it is currently not
clear whether advantages or disadvantages of ultra high ﬁeld systems
prevail for functional clinical diagnostics.
Given the fact that clinical 3 T high ﬁeld systems are now widely
available, this study investigated whether there are diagnostic
beneﬁts for a standardized fMRI investigation when progressing
from 3 T to 7 T in a clinical setting. A frequently requested presurgical
localization of the primary motor hand area was chosen as clinically
relevant task. We concentrated on results achievable with identical
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optimizations performed according to the current state of the art.
Important clinical image parameters such as matrix size and ﬁeld of
view were kept constant, as was the analysis approach. Evaluation
concentrated on key parameters for assessing functional sensitivity,
including percentage signal change, contrast to noise ratio and
statistical parameters within functional regions of interest (ROIs).
Our hypothesis was that a clinically relevant beneﬁt, evidenced
through functional sensitivity, would be present for fMRI studies in
brains affected by pathology at 7 T.
Materials and methods
Patients
Seventeen patients (6 females, mean age 40.5 years old and 11
males, mean age 25.3 years old; age range 9–70 years of age),
consecutively referred for presurgical diagnostics, participated in
the study (see Table 1 for demographic and clinical details). For all
patients, a functional localization of the motor hand area for the
clinically affected hand had been requested by physicians, for a
number of reasons. No exclusion criterions were applied. At the time
of measurement, all patients were of good general constitution, could
move the relevant hand against resistance and could perform the
motor task well. The study was approved by the ethics committee of
the Medical University of Vienna. All patients gave written informed
consent.
Task
The functional paradigm was a simple motor task: repetitive
opening and closing of the affected hand with eyes open. The healthy
hand was investigated in peripheral nerve patient P8 due to
exceptional paresis (see Table 1). One run consisted of four rest (A)
and three movement phases (B) of 20 s each presented in a blocked
ABABABA design. Depending on the patient's tolerance, between four
and eight runs were accomplished. Instructions – when to begin and
when to stop the action – were communicated to the patients via
headphones. Patients were requested to perform the task at a rate of
1 Hz (for each cycle of opening and closing the hand) and were
assisted in achieving this via a visually presented indicator; a circle,
which was cyan for 0.5 s, then red for 0.5 s. The visual input during
rest phases was identical.Table 1
Demographic and clinical details of the patients studied.
Patient Sex Age Side of
pathology
Pathological diagnosis at the time of fMRI
P1 f 34 Right Frontal tumor, unknown origin
P2 m 28 Right Frontal tumor, unknown origin
P3 m 16 Right Parietooccipital malformations (Sturge Weber)
P4 m 70 Left Central recurring glioblastoma
P5 m 21 Right Temporal astrocytoma (II°)
P6 m 38 Left Frontal low grade glioma
P7 f 32 Left Temporal glioblastoma
P8 f 31 Right End to side coaptation right phrenic nerve to right
musculocutaneous nerve after complete brachial
plexus lesion right. fMRI data from the healthy
left hand.
P9 m 11 Right Fronto-central focal cortical dysplasia
P10 m 14 Right Cryptogenic temporal lobe epilepsy
P11 m 9 Left Central focal cortical dysplasia
P12 f 38 Left Opercular oligoastrocytoma (II°)
P13 f 55 Left Left pre-central tumor, unknown origin
P14 m 21 Right Central low grade glioma
P15 m 21 Left Post-central polycystic astrocytoma
P16 m 29 Right Postcentral tumor, unknown origin
P17 F 53 Left Parietal tumor, unknown originImage acquisition
Patients were examined with both a 3 T Siemens MAGNETOM TIM
TRIO scanner and a 7 T Siemens MAGNETOM scanner (Siemens,
Erlangen, Germany). Measurements at the two ﬁeld strengths were
typically carried out within 10 days. However, for clinical reasons, for
2 patients this interval had to be increased (to 37 days for P11, to
62 days for P12). To minimize head motion artifacts, individually
constructed plaster cast helmets (Edward et al., 2000) were used on
both systems. A 32 channel Siemens head coil (Siemens, Erlangen,
Germany) was used for 3 T measurements. For 7 T measurements, a
24 channel head coil was applied for P1–P15, while – due to a system
upgrade involving a coil exchange – P16 and P17 were measured with
a 32 channel head coil (both manufactured by Nova Medical,
Wilmington, Massachusetts, USA). On both systems, functional MRI
data were acquired with a 2D single-shot gradient echo (GE) EPI
sequence, with slices aligned parallel to the AC-PC plane and whole
brain coverage. Simple system-speciﬁc sequence optimizations were
performed according to requirements for whole brain coverage and
recommendations in the literature.Common sequence parameters
FOV 230 mm, matrix size 128×128×34, 56 repetitions, slice
thickness 3 mm, TR: 2500 ms, parallel imaging with GRAPPA-iPAT
factor 2, fat suppression by a chemical shift selective saturation pulse
prior to every slice, 10 s of dummy scans.Differing sequence parameters
3 T: TE 28 ms, bandwidth 2220 Hz, ﬂip angle 90°, full Fourier
encoding, no gap between slices. Vendor provided fat saturation
module with a preset ﬂip angle of 110°.
7 T: TE 22 ms, bandwidth 1445 Hz (P1 1220 Hz, P4 1395 Hz to
reduce ghosting), ﬂip angle 80°, 6/8 partial Fourier factor (omitting
the ﬁrst 25% of k-space phase-encoding lines), 10% gap between
slices. The effective echo time at 7 T was optimized via assessment
of T2* for this resolution. Flip angles of the vendor-provided fat
saturation module were reduced to 90° due to speciﬁc absorption
rate (SAR) limitations.
At each ﬁeld strength, high-resolution sagittal T1-weighted MR
images were acquired using a 3D MPRAGE sequence for visualizing
anatomical details. However, these images did not enter data analysis
in the current study.fMRI data analysis
Functional data were pre-processed and statistical analysis was
performed using SPM8 (Wellcome Department of Imaging Neurosci-
ence, London, UK; http://www.ﬁl.ucl.ac.uk/spm). To reduce residual
small-scale motion, all runs were registered to the ﬁrst scan using
default settings except for the factors “Quality: 0.95” and “Separation:
2”, both chosen to improve correction quality. No slice timing
correction or spatial normalization was carried out. Functional images
were smoothed with a 4×4×6 mm full width at half maximum
(FWHM) Gaussian kernel. First level statistical analysis was per-
formed with a mixed effects analysis (default settings, no additional
temporal ﬁltering or averaging) with inclusion of motion parameters
in the design matrix as nuisance variables. BOLD responses were
modeled by a ﬁxed response boxcar function convolved with the
canonical hemodynamic response. Activationwas established for each
patient via voxel-wise t-tests to generate individual SPM t-maps. The
same number of 3 T and 7 T runs were analyzed for each patient. All
superﬂuous runs were excluded (by acquisition order, to avoid bias).
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First, individual neuroanatomical ROIs comprising the inverted
omega structure around the central sulcus (the primary motor hand
area) were manually deﬁned by a neurologist (Figs. 1 and 2). The ROI
deﬁnitions were carried out separately for each ﬁeld strength. All
activated voxels (pb=0.05, family-wise error (FWE) — corrected,
(Nichols and Hayasaka, 2003)) within the predeﬁned ROI formed the
resulting functional ROI. The validity of the functional ROIs was
veriﬁed by visually inspecting individual SPM t-maps superposed on
an individual EPI image (mean image after realignment). Given that
the size of regions identiﬁed as being active may increase with the
ﬁeld strength, this procedure assured inclusion of all relevant primary
motor activations and reduced the inﬂuence of non-primary cortex
activity on ﬁnal results.Data quantiﬁcation
To assess effects related to the two ﬁeld strengths, we analyzed only
signiﬁcant voxels in the functional ROIs and compared six measures
relevant to functional activation: (1) voxel count (number of supra-
threshold voxels), (2) mean t-value, (3) peak t-value, (4) percentage
signal change, (5) contrast to noise ratio (CNR) (Geissler et al., 2007)Fig. 1. Patient P6. A: Functional EPI slices covering central parts of the primary motor hand a
hand area (light green). C: Same as B with depiction of all suprathreshold voxels (pb=0.05, F
analysis and formed the functional ROI. Color bar indicates t-values of active voxels (3 T mand (6) peak CNR. To evaluate relevant sources of artifacts, a metric for
head motion and a ghost to signal ratio were also calculated.Quantiﬁcation of functional activation
Measures (1) Voxel count, (2) Mean t-value and (3) Peak t-value. For
each patient, all voxels included in the functional ROIs (fROIs) were
separately analyzed for the 3 T and 7 T experiments. The voxel count
(the number of voxels in the fROI), the mean t-value of all fROI voxels
and the highest t-value of all fROI voxels were determined.Measure (4) Percentage signal change. Percentage signal change, ΔS/
SOFF, was calculated according to the deﬁnition of van der Zwaag et al.
(2009, c.f. section “Analysis”). In brief ΔS=(SON-SOFF), where SON is the
mean absolute signal of all time points within “ON” phases and SOFF is
the mean of all time points within “OFF” phases (arithmethic mean,
voxel-wise calculation). For the deﬁnition of ON and OFF phases the
underlying block design of the paradigm was shifted by ﬁve seconds to
accord with the delayed BOLD response. This calculation was
performed for all voxels within the fROI separately for every run of
each patient followed by arithmetic averaging to achieve one
representative ﬁgure per patient and ﬁeld strength.rea at 3 T and 7 T. B: Same as A with neuroanatomical ROIs depicting the primary motor
WE— corrected) within the neuroanatomical ROIs. Only these voxels entered statistical
aximum=22.3, 7 T maximum=25.3).
Fig. 2. Patient P13. Same es Fig. 1. 3 T t-value maximum=11.8, 7 T t-value maximum=15.2).
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noise ratio. CNR was calculated from ΔSCNR/σt-noise, as deﬁned in
Geissler et al. (2007), paragraph “CNR Calculation Using Savitzky-Golay
(SG) Filters (CNR_SG)”. Essentially, the contrast ΔSCNR is the averaged
voxel-wise signal change in the temporally smoothed original signal:
(mean value of all time points within the “ON” phase) – (mean value
of all time points within the “OFF” phase). ON/OFF deﬁnitions were
the same as for the percentage signal change analysis (measure 4, see
above). Smoothingwas performed using a Savitzky–Golay ﬁlter with a
polynomial order of 2 and length 5. σt-noise is the non-task-related
variability over time — in this case the standard deviation of the
difference between the original and smoothed signals. Again, this
calculationwas done for all voxels within the functional ROI and every
run of each patient, followed by arithmetic averaging to achieve one
representative number per patient and ﬁeld strength. The patient's
peak CNR was determined by analyzing the mean CNR values of all
ROI voxels separately for the 3 T and 7 T experiments to detect the
voxels with the largest 3 T / 7 T CNR.
Calculation of motion indicator for head motion quantiﬁcation
Head motion was quantiﬁed at both ﬁeld strengths using the
parameters resulting from the motion correction procedure of SPM8.
It was hypothesized that headmotionmay differ betweenMR systems
due to the different dimensions of the magnet (3 T/7 T=2.13 m/4 m
length), head coils and head ﬁxation helmets (Edward et al., 2000). Toevaluate head motion, a global parameter was calculated separately
for translation and rotation. Translation: integrating x-, y-, and z-axis
values, the Euclidian distance (in mm) between successive volumes
was determined for every run. The median of these between-volume
distances was taken used as a single-parameter metric for motion.
Rotation: for each angle (pitch, roll, yaw) between-volume rotations
were assessed and the median between-volume rotation (in rad) was
determined over all volumes of all runs per patient and axis.
Calculation of ghost to signal ratio for quantiﬁcation of ghosting artifacts
Parallel imaging (PI) allows phase-encoding steps to be omitted,
enabling resolution to be increased (while achieving the same
effective echo time) and distortion to be decreased. In this study,
generalized auto-calibrating parallel acquisition (GRAPPA) factor 2
was used at both ﬁeld strengths (Griswold et al., 2002). With
acceleration, image quality is reduced by patient motion, which
affects the applicability of reference lines and leads to ghost-like
artifacts (Skare et al., 2007). To determine the magnitude of these
artifacts we deﬁned a ghost to signal ratio similar to that deﬁned in
the EU COMAC-BME II project (Lerski and de Certaines, 1993). Two
types of ROIs were deﬁned (Fig. 3): a central reference ROI — in a
homogenous region of white matter within the brain and one anterior
and one posterior ghosting ROI — comprising ghosting artifacts
occurring in the phase-encode direction. ROI selection was performed
within three slices adjacent to the central slice of the EPI dataset. For
Table 2
Summary of results.
Measure 3 T Value
(SD)
7 T Value
(SD)
P-value
Voxel count 666 (292) 896 (385) 0.0007
Mean t-value 10.7 (2.4) 11.6 (2.1) 0.04
Peak t-value 24.7 (8.0) 25.6 (6.6) n.s.
Percentage signal change
(%, mean of fROI)
1.8 (0.5) 2.3 (0.7) 0.004
Contrast to noise ratio (CNR) 3.3 (0.7) 4.3 (0.8) 0.00000002
Peak CNR 9.7 (3.2) 13.0 (3.3) 0.0000001
Motion indicator — Translation (mm) 0.04 (0.03) 0.09 (0.06) 0.005
Motion indicator — Rotation (rad)
Pitch 1.9E-5
(4.5E-5)
2.0E-5
(1.1E-4)
n.s.
Roll 5.4E-6
(5.1E-5)
1.0E-5
(3.7E-5)
n.s.
Yaw 1.5E-6
(8.2E-5)
2.8E-5
(1.8E-4)
n.s.
Ghost to signal ratio 0.05 (0.02) 0.13 (0.07) 0.00007
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between the mean absolute signal within the ghosting ROIs to the
mean signal in the central reference ROI.
Statistical evaluation of 3 T–7 T differences
After testing for normal distribution, paired t-tests comparing 3 T
and 7 T values were calculated over all patients for voxel count, mean
t-value, peak t-value, percentage signal change, CNR, peak CNR,
motion indicator and ghost to signal ratio.
Results
The primary metrics described in “Data quantiﬁcation” are
summarized in Table 2 for 3 T and 7 T measurements. All measures
of functional activation showed a statistically signiﬁcant beneﬁt for
the 7 T system, except for peak t-value, which showed no signiﬁcant
difference between 3 T and 7 T data. None of the measures indicated
advantage for the 3 T system. Figs. 1 and 2 show typical activation
changes from 3 T to 7 T. Fig. 4 illustrates the mean signal and CNR
increase with the 7 T system.
While functional signal changes were greater, 7 T measurements
suffered from a signiﬁcant increase in artifacts: translational head
motions were signiﬁcantly larger (c.f. Fig. 5, rotation n.s.) and
ghosting was substantially increased (see Fig. 6).
As part of a hardware upgrade the 24-channel coil which was used
for the study of patients P1-15 was replaced by a 32-channel coil,
which was used for measurement of P16 and P17. The main results –
signiﬁcant improvement in all performance metrics other than peak
t-value – hold if P16 and P17 are excluded from the analysis.
Discussion
This study provides ﬁrst data on the possible beneﬁt of ultra high
ﬁeld systems for clinical fMRI. It is well known that imaging problems
such as geometric distortions, signal dropouts and B1 inhomogeneity
increase at very high ﬁeld. The deleterious effects on functional
images of pathological brains are not known. Correspondingly, it is
not clear whether the potential beneﬁts of 7 T systems may be
realized in practice in clinical fMRI.
Previous ultra high ﬁeld studies performed with healthy subjects
typically used limited ﬁeld of views (FOV) and, other than Gizewski et
al. (2007) no functional whole brain coverage e.g. (Duong et al., 2003;
Olman et al., 2010; van der Zwaag et al., 2009; Yacoub et al., 2001).
This was due to technical limitations in some ﬁrst-generation
scanners and also to SAR limitations. However, the typical demand
for a clinical application is whole brain coverage, since shifts of
essential cortical areas due to pathology and functional reorganization
are not predictable prior to the functional investigation. AnotherFig. 3. Position of ROIs for quantiﬁcation of ghosting artifacts (P6, 3 T data). Blue: ROIs for det
absolute signals within the ghosting ROIs to the reference ROIs was calculated.important problem with pathological brains concerns errors intro-
duced by registration/normalization procedures or atlas-based region
of interest deﬁnitions (Beisteiner et al., 2010; Gartus et al., 2007). To
account for these issues, we performed whole brain coverage with a
multichannel coil and a sub-maximal but clinically typical spatial
resolution and data analysis on non-transformed individual functional
images. The application of multichannel coils in this study enabled
parallel imaging to be applied, which effectively reduced image
distortions. Our motor task was standardized by visual triggering and
represented a typical clinical paradigm which assured similar
performance in both MR systems.
We performed a standard SPM8 data analysis with all individual
data sets (FWEb0.05, motion parameters included as covariates of no
interest, independent analysis of 3 T and 7 T data) and deﬁned
functional ROIs (fROIs) for primary motor hand activation. With the
given task and an adequate amount of functional data, fROI deﬁnitions
are possible with high reliability in pathological brains (Roessler et al.,
2005). Our data analysis approach reduces the inﬂuence of non-
primary cortex activity on the ﬁnal results and minimizes effects
related to postprocessing data transformations. To allow a compre-
hensive interpretation of 3 T–7 T differences and common grounds
with previous studies (e.g. van der Zwaag et al., 2009), several
measures were extracted from the functional ROIs: voxel count, mean
t-value, peak t-value, percentage signal change, contrast to noise ratio
(CNR) and peak CNR. The CNR analysis allows investigation of the data
with minimal model assumptions, since it is not dependent on the
shape of the hemodynamic response function but only on the mean
signal increase during the “ON” phase (Geissler et al., 2007). As withection of ghosting signals, Green: central reference ROI. The relation between the mean
Fig. 4. Signal time course differences averaged over all peak CNR voxels of all patients.
Fig. 6. Quantiﬁcation of ghosting signals. The ghost to signal ratio is signiﬁcantly larger
with the 7 T system. Data show mean and standard deviation of the patient speciﬁc
ghost to signal ratios.
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used. However, for every clinical report a threshold needs to be
deﬁned (see discussion in (Beisteiner et al., 2010)). Here we used
identical statistical models for 3 T and 7 T data and a well established
threshold (FWE pb0.05) often used for clinical reports. Therefore, we
consider it justiﬁed to regard these results as being relevant for
patient investigations. Since our focus was on evaluating ﬁnal fMRI
results typically used for generating clinical reports – and correspond-
ing to most previous studies investigating BOLD signal changes as a
function of ﬁeld strength – we did not directly measure the effect of
changes of relaxation rates on activation. However, we evaluated the
possible inﬂuence of typical sources of artifacts by quantifying the
amount of ghosting and head motion.
The results demonstrate a signiﬁcant 7 T beneﬁt for all functional
measures apart from peak t-value. The latter ﬁnding might be related
to the increased artifact contamination of the 7 T data which might
have more impact when comparing individual voxels instead of
clusters. Patients showed signiﬁcantly more head motion in the 7 T
system, most probably due to the inferior head ﬁxation (due to space
restrictions in the 7 T head coil) and inferior comfort compared to the
clinical 3 T system (space, noise, light…). In addition, ghosting artifacts
were signiﬁcantly larger in our 7 T images. Given the 3 T/7 TFig. 5. Quantiﬁcation of head motion. Translational head movements between two
consecutively recorded brain volumes are larger with the 7 T system. Data show mean
and standard deviation of the patient speciﬁc motion indicators.experimental standardizations and application of standard thresholds,
increase of activation sensitivity and activation volume should be a
direct consequence of better SNR/CNR at 7 T. This corresponds to
previous literature e.g. (Logothetis et al., 2001) which indicates that the
fMRI signals „underestimate a great deal of actual neural activity“.
Further, investigations concerned with sensitivity for tissue/draining
veins indicate that there should also be a beneﬁt for reduced sensitivity
to larger and draining veins (relative to sensitivity for tissue signals) at
7 T (Duonget al., 2003;Gati et al., 1997;Ogawaet al., 1998;Yacoubet al.,
2001). The patients investigated in this study represent a typical clinical
population. Inclusion was based solely on requests for motor localiza-
tions that were not inﬂuenced by the authors. It is also notable that we
limited our procedures to system-speciﬁc setup and simple sequence
optimizations performed according to the literature (e.g. Speck et al.,
2008) — an approach feasible in every clinical context. The measure-
ments were clinically standardized (including identical spatial resolu-
tion and whole brain coverage) and both MR systems were from the
same manufacturer and current technical state of the art (including
identical gradients and commercially availablemulti-channel head coils
with a similar basic design and number of channels). Our results
therefore represent realistic clinical outcome conditions and indicate
that a functional 7 T beneﬁt is not limited to special application
conditions such as preselected patients or atypical coils and fMRI
sequences. Interestingly, our ﬁndings are quite similar to previously
reported results in healthy subjects, where signiﬁcant 7 T beneﬁts were
established for voxel count, mean t-value and percentage signal change
(van der Zwaag et al., 2009, CNR analysiswas not performed). Therefore
the beneﬁt for patients accords well with that established with normal
subjects. Of course, our results cannot be extrapolated to other fMRI
paradigms or areas of the brain more prone to artifacts (inferior frontal
cortex, basal temporal cortex). Such investigations have yet to be
undertaken.
It is evident that comparisons of fMRI results from different MR
systems may be inﬂuenced by numerous factors including hardware
speciﬁcations, hardware quality, coils, software speciﬁcations, MR
sequence details and differing patient states due to differing system
environments. For example, it has been shown that high-ﬁeld beneﬁts
are greatest at high resolution, a regime in which physiological noise
is smallest relative to the thermal noise (Triantafyllou et al., 2005).
However, Triantafyllou et al. also show that the tSNR gain for 7 T over
3 T reaches a maximum for voxel sizes of about 2×2×3 (at ratio of
approximately 1.32). Further reductions in voxel size bring no
additional increase in the ratio of tSNR measured at 7 T compared to
1021R. Beisteiner et al. / NeuroImage 57 (2011) 1015–10213 T. The resolution used here was close to that at which Triantafyllou
et al. observed the greatest increase in time-series SNR at 7 T over 3 T,
so at most only a modest beneﬁt is to be expected for comparison
studies carried out at higher spatial resolution.
TheMR environmentmay inﬂuence the general arousal state, which
may also have consequences for the fMRI results (Nagai et al., 2004).
Although we were able to establish comparability of ﬁnal results for a
clinical context (for instance, by applying a spatial standard resolution
andmatchedmeasurement times), it is evident that the full potential of
7 T systems has not yet been exhausted with our setup. In fact, many
factors differing between the 3 T and 7 T measurement in this study
beneﬁt the3 Tmeasurements. In the3 T studyweused a32-channel coil
(whereas most 7 T measurements were made with a 24–channel coil),
full Fourier encoding, better head ﬁxation and a more comfortable
environment. The latter two factors led to markedly less head motion.
The single (and modest) advantage in the 7 T study was the 10% gap
allocation. Quite obviously, it is not possible to establish “identical”
hardware setups and exact replications of sequence parameters or carry
out a functional study with systematic variation of all relevant
parameters. Additional investigations are required to clarify which
parameter optimizations aremost promising for a further increase of 7 T
functional signal beneﬁts in a clinical context.
Despite these qualiﬁcations, we conclude that 7 T systems enable a
clinically relevant increase in functional sensitivity for patient
investigations.Acknowledgment
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